INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
Federal contract awards won by INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. (UEI Z82HHPY83MC7), 2022–2026 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
5
awards
1
expiring in 12 months
1
agency
Teaming snapshot
teams under 1 prime.
From subcontract reports primes file with USAspending/FSRS.
Where their reported work happens
| State | Reported subawards |
|---|---|
| NY | 2 |
Place of performance on subcontract reports filed with USAspending/FSRS.
Category award history
4 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: OXFORD NANOPORE TECHNOLOGIES INC took Department of Health and Human Services 541714 work from INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. (Oct 29, 2025).
Agencies buying from INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
What INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. has provided
Awards
BAA CONTRACT - DEVELOPMENT OF SUSCEPTIBILITY GUIDANCE FOR DAPTOMYCIN AND ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
Department of Health and Human Services · $325,000 · Aug 1, 2026
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREA C
Department of Health and Human Services · No current value reported · Jul 15, 2024
THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR AMPICILLIN AND VANCOMYCIN FOR ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
Department of Health and Human Services · $263,016 · Sep 18, 2023
A STUDY IN THE "DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR ORAL SULFAMETHOXAZOLE-TRIMETHOPRIM USING PHARMACOMETRICS APPROACHES" BAA PMWP #195
Department of Health and Human Services · $291,142 · Sep 22, 2022
COMBATTING ANTIBIOTIC RESISTANT BACTERIA (CARB) PROGRAM
Department of Health and Human Services · $291,618 · Sep 21, 2022